首页> 外文期刊>Asian journal of research in chemistry >First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Nebivolol Hydrochloride and Indapamide in Tablet Dosage Form
【24h】

First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Nebivolol Hydrochloride and Indapamide in Tablet Dosage Form

机译:一阶导数分光光度法同时测定片剂中盐酸奈必洛尔和吲达帕胺的含量

获取原文
获取原文并翻译 | 示例
           

摘要

Accurate, precise, rapid and economical spectrophotometric method was developed for the estimation of Indapamide and Nebivolol in bulk dosage form. In first order derivative spectrophotometry, wavelengths selected for quantitation were 271.40nm for Nebivolol (zero crossing point for indapamide) and 244.90nm for Indapamide (zero crossing point for nebivolol). The method was validated as per ICH guideline. In this method the linearity was observed in the concentration range of 6-30μg/ml for Nebivolol and 2-10μg/ml for Indapamide. The accuracy and precision were determined and found to comply with ICH guidelines. The proposed method was successfully applied for the simultaneous estimation of both drugs in commercial tablet preparation.
机译:建立了准确,准确,快速,经济的分光光度法测定大剂量剂型吲达帕胺和奈必洛尔的方法。在一阶导数分光光度法中,选择用于定量的波长对于奈比洛尔(对于茚达帕胺为零交叉点)为271.40nm,对于吲哚帕胺(对于奈比洛尔为零交叉点)为244.90nm。该方法已按照ICH指南进行了验证。在这种方法中,奈必洛尔的浓度范围为6-30μg/ ml,吲达帕胺的浓度范围为2-10μg/ ml。确定了准确性和精密度,并发现它们符合ICH指南。所提出的方法已成功应用于商业片剂制备中两种药物的同时估算。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号